[1]
2026. PERSONALIZED MOLECULARLY GUIDED MANAGEMENT OF ATOPIC DERMATITIS: PROGNOSTIC STRATIFICATION AND CLINICAL OUTCOMES IN A 300-PATIENT COHORT. INTERNATIONAL CONFERENCE ON INTERDISCIPLINARY SCIENCE. 3, 9 (Oct. 2026), 45–47.